Claire Bugos

Key Takeaways The FDA declined to approve MDMA as a treatment for PTSD, requesting further clinical trials to address safety concerns and data integrity.

Fact checked by Nick Blackmer Fact checked by Nick Blackmer Key Takeaways

The Centers for Medicare and Medicaid Services reached agreements to cut the cost of 10 of the most commonly prescribed and expensive medications for seniors and Medicare Part D enrollees.

Zepbound and Mounjaro reduce the risk of developing type 2 diabetes by 94% in people who have prediabetes and obesity or overweight.

Fact checked by Nick Blackmer Fact checked by Nick Blackmer Key Takeaways

A new anti-obesity medication from Novo Nordisk targets GLP-1 and amylin in a daily oral tablet.

Self-collection HPV tests are now available in doctor's offices and other healthcare settings nationwide to screen for cervical cancer without a pelvic exam.

Illustration by Zoe Hansen for Verywell Health Key Takeaways The FDA has approved Cobenfy, the first new schizophrenia treatment in over 30 years.

U.S. clinicians often lack training in evaluating adult ADHD. A forthcoming set of national clinical guidelines will finally provide some clarity.

Older adults and immunocompromised people should get a second dose of the updated COVID vaccine six months after their shot this fall, the CDC said.